Glycosylation inhibitors in biology and medicine
- 1 October 1995
- journal article
- review article
- Published by Elsevier in Current Opinion in Structural Biology
- Vol. 5 (5), 605-611
- https://doi.org/10.1016/0959-440x(95)80051-4
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Treatment with the α-glucosidase 1 inhibitor 6-O-butanoyl castanospermine reduces the detection of LFA-1 (CD18/CD11a) by monoclonal antibodiesGlycobiology, 1995
- Castanospermine analogues: their inhibition of glycoprotein processing α-glucosidases from porcine kidney and B16F10 cellsGlycobiology, 1995
- Long-term efficacy and safety of acarbose in the treatment of obese subjects with non-insulin-dependent diabetes mellitusArchives of Internal Medicine, 1994
- Effect of glycosidase inhibitors on the biosynthesis of α2-plasmin inhibitor and antithrombin III in Hep G2 cellsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1994
- Efficacy of 24-Week Monotnerapy With Acarbose, Glibenclamide, or Placebo in NIDDM Patients: The Essen StudyDiabetes Care, 1994
- Introduction of oxygen into the alkyl chain of N-decyl-dNM decreases lipophilicity and results in increased retention of glucose residues on N-linked oligosaccharidesGlycobiology, 1994
- AcarboseDrugs, 1993
- Alpha‐glucosidase Inhibition as an Adjunct to the Treatment of Type 1 DiabetesDiabetic Medicine, 1993
- Inhibition of scavenger receptor-mediated modified low-density lipoprotein endocytosis in cultured bovine aortic endothelial cells by the glycoprotein processing inhibitor castanospermineBiochemistry, 1993
- Modulation of cell‐surface transferrin receptor by the imino sugar N‐butyldeoxynojirimycinEuropean Journal of Biochemistry, 1992